Equity Capital Markets

All filings · since 4 November 2002

Filings

Every share-offering filing on EDGAR since the day foreign issuers also had to file electronically. One row per filer: a filing made by a parent and its subsidiaries appears once for each of them, as in SEC's own index.

Page 1 · newest first · 50 per pageDownload as CSV (up to 5,000 rows)
FiledCompanyFilingAccession
2017-03-30
Orexigen Therapeutics, Inc.
ShelfEffectiveCIK 1382911
 424B5Shelf takedown0001193125-17-104055
2016-05-16
Orexigen Therapeutics, Inc.
ShelfEffectiveCIK 1382911
 EFFECTDeclared effective9999999995-16-004672
2016-03-15
Orexigen Therapeutics, Inc.
ShelfEffectiveCIK 1382911
 S-3Shelf registered0001193125-16-505252
2016-02-03
Orexigen Therapeutics, Inc.
ShelfEffectiveCIK 1382911
 EFFECTDeclared effective9999999995-16-003662
2015-11-12
Orexigen Therapeutics, Inc.
ShelfEffectiveCIK 1382911
 S-3Shelf registered0001193125-15-375632
2012-10-25
Orexigen Therapeutics, Inc.
ShelfEffectiveCIK 1382911
 424B5Shelf takedown0001193125-12-435470
2012-10-24
Orexigen Therapeutics, Inc.
ShelfEffectiveCIK 1382911
 424B5Shelf takedown0001193125-12-433285
2012-10-04
Orexigen Therapeutics, Inc.
ShelfEffectiveCIK 1382911
 EFFECTDeclared effective9999999995-12-002906
2012-09-14
Orexigen Therapeutics, Inc.
ShelfEffectiveCIK 1382911
 S-3Shelf registered0001193125-12-392671
2011-12-15
Orexigen Therapeutics, Inc.
ShelfEffectiveCIK 1382911
 424B5Shelf takedown0001193125-11-342371
2011-12-14
Orexigen Therapeutics, Inc.
ShelfEffectiveCIK 1382911
 424B5Shelf takedown0001193125-11-341066
2009-09-17
Orexigen Therapeutics, Inc.
ShelfEffectiveCIK 1382911
 EFFECTDeclared effective9999999995-09-002591
2009-09-04
Orexigen Therapeutics, Inc.
ShelfEffectiveCIK 1382911
 S-3Shelf registered0001193125-09-187567
2009-07-24
Orexigen Therapeutics, Inc.
ShelfEffectiveCIK 1382911
 424B5Shelf takedown0001193125-09-154529
2009-07-22
Orexigen Therapeutics, Inc.
ShelfEffectiveCIK 1382911
 424B5Shelf takedown0001193125-09-153234
2009-05-14
Orexigen Therapeutics, Inc.
ShelfEffectiveCIK 1382911
 EFFECTDeclared effective9999999995-09-001423
2009-05-06
Orexigen Therapeutics, Inc.
ShelfEffectiveCIK 1382911
 S-3Shelf registered0001193125-09-101682
2008-01-24
Orexigen Therapeutics, Inc.
Registered companyFinal prospectusCIK 1382911
 424B4Final prospectus0000950134-08-001010
2008-01-23
Orexigen Therapeutics, Inc.
Registered companyFinal prospectusCIK 1382911
 EFFECTDeclared effective9999999995-08-000260
2008-01-14
Orexigen Therapeutics, Inc.
Registered companyFinal prospectusCIK 1382911
 S-1/AAmendment0000950134-08-000483
2008-01-07
Orexigen Therapeutics, Inc.
Registered companyFinal prospectusCIK 1382911
 S-1Registration filed0000936392-08-000012
2007-04-26
Orexigen Therapeutics, Inc.
IPOFinal prospectusCIK 1382911
 424B4Final prospectus0000936392-07-000334
2007-04-25
Orexigen Therapeutics, Inc.
IPOFinal prospectusCIK 1382911
 EFFECTDeclared effective9999999995-07-001465
2007-04-25
Orexigen Therapeutics, Inc.
IPOFinal prospectusCIK 1382911
 S-1/AAmendment0000936392-07-000325
2007-04-09
Orexigen Therapeutics, Inc.
IPOFinal prospectusCIK 1382911
 S-1/AAmendment0000936392-07-000270
2007-02-16
Orexigen Therapeutics, Inc.
IPOFinal prospectusCIK 1382911
 S-1/AAmendment0000936392-07-000129
2007-01-23
Orexigen Therapeutics, Inc.
IPOFinal prospectusCIK 1382911
 S-1/AAmendment0000936392-07-000042
2006-12-19
Orexigen Therapeutics, Inc.
IPOFinal prospectusCIK 1382911
 S-1Registration filed0000936392-06-001139